Astral Pharmaceuticals Private Limited, a active private limited company, was established on 09 May 2006 in Worli, Maharashtra, India. Engaging in pharmaceutical retailers & distributors within the trade sector, it holds CIN: U24231MH2006PTC161708. Registered under ROC Roc Mumbai. it is unlisted. It has an authorized capital of ₹2.00 M and a paid-up capital of ₹1.71 M.
Formerly known as Anovaa Pharma Private Limited. It upholds a compliant status. Its leadership includes Shyam Sundar Jajodia (Director), Ajaay Shyamsundar Jajodia (Director). Past directors included Sankalp Agrawal Omprakash, Anup Murarilal Jhunjhunwala, Shyam Sundar Jajodia. Its latest AGM occurred on 30 September 2025, with the balance sheet filed on 31 March 2025. It is based at A-10, Floor-2Nd, Plot -8,A, Pankaj Mansion, Dr Annie Besant Road, Worli Naka, Worli, Maharashtra, 400018.
U24231MH2006PTC161708
161708
09 May 2006
₹2.00 M
₹1.71 M
Roc Mumbai
Unlisted
Active
Explore comprehensive insights into Astral Pharmaceuticals Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Shyam Sundar Jajodia | Director | 02 Nov 2012 | Current |
| Ajaay Shyamsundar Jajodia | Director | 15 Apr 2022 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Additional Director | 15 Apr 2022 | Past |
| Pramod Abcsdd | Director | 31 Jan 2013 | Past |
| Pramod Abcsdd | Director | 19 Feb 2010 | Past |
| Pramod Abcsdd | Director | 07 Sep 2020 | Past |
| Pramod Abcsdd | Director | 28 Sep 2021 | Past |
| Pramod Abcsdd | Director | 28 Jan 2015 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Astral Pharmaceuticals Private Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 62.78% decrease. The company also saw a substantial fall in profitability, with a 120.93% decrease in profit. The company's net worth dipped by a decrease of 0.04%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2023, Astral Pharmaceuticals had a public holding of 91.25%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
There are no open charges registered against the company as per our records.
Unlock and access historical data on people associated with Astral Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Astral Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Astral Pharmaceuticals's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
The activity Astral Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records. was completed.
Astral Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Mumbai. was recorded as a recent event.
Progress on Ajaay Shyamsundar Jajodia was appointed as a Director was appointed as a Director on 15 Apr 2022 & has been associated with this company since 3 years 7 months . was documented.
Progress on Shyam Sundar Jajodia was appointed as a Director was appointed as a Director on 02 Nov 2012 & has been associated with this company since 13 years 27 days . was documented.
The activity Astral Pharmaceuticals Private Limited was registered on 09 May 2006 with Roc Mumbai & aged 19 years 6 months as per MCA records. was completed.
The CIN of Astral Pharmaceuticals Private Limited is U24231MH2006PTC161708.
Astral Pharmaceuticals Private Limited is headquartered at A-10, Floor-2Nd, Plot -8,A, Pankaj Mansion, Dr Annie Besant Road, Worli Naka, Worli, Maharashtra, 400018.
Astral Pharmaceuticals Private Limited was incorporated on 09 May 2006.
The current directors of Astral Pharmaceuticals Private Limited are
The primary industry of Astral Pharmaceuticals Private Limited is Trade.
Astral Pharmaceuticals Private Limited is unlisted.
The authorized capital of Astral Pharmaceuticals Private Limited is ₹2.00 M, and the paid-up capital is ₹1.71 M.
The compliance status of Astral Pharmaceuticals Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX